Isocitrate Dehydrogenase 1 (NADP+) human, >=0.30 mg/mL protein basis (Bradford);, recombinant, expressed in Sf9 cells, >=90% (SDS-PAGE)

Code: i2411-10ug D2-231

Not available outside of the UK & Ireland.

Application

Human Isocitrate Dehydrogenase (IDH1) is useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. It may be useful as a biomarker...


read more

Your Price
$727.90 10UG

Not available outside of the UK & Ireland.

Application

Human Isocitrate Dehydrogenase (IDH1) is useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. It may be useful as a biomarker for diagnosis and prognosis prediction of non-small cell lung cancer .

Biochem/physiol Actions

Human Isocitrate Dehydrogenase (IDH1), also known as oxalosuccinate decarboxylase, is a full length amino acid with a C-terminal FLAG-tag and is expressed in Sf9 cells via a baculovirus expression system. IDH1 expression has been correlated with poor survival of non-small cell lung cancer. IDH1 promotes tumor growth .

General description

Human Isocitrate Dehydrogenase (IDH1), also known as oxalosuccinate decarboxylase, full length [amino acids 1-414 (end)] with C-terminal FLAG-tag, expressed in Sf9 cells via a baculovirus expression system.

Physical form

Solution in 45 mM Tris-HCl, 124 mM NaCl, 2.4 mM KCl, 90 µg/ml FLAG peptide, 3 mM DTT, and 10% glycerol at pH 8.0.

assay≥90% (SDS-PAGE)
concentration≥0.30 mg/mL protein (Bradford)
formbuffered aqueous glycerol solution
mol wt47.6 kDa
NCBI accession no.NM_005896
Quality Level200
recombinantexpressed in Sf9 cells
relevant disease(s)cancer (lung)
shipped indry ice
storage temp.−70°C
Cas Number9028-48-2
This product has met the following criteria: